Sherene Min

5.7k citations
50 papers · 4.9k · 4 hit papers · h-index 27

Impact in

    • HIV/AIDS drug development and treatment
    • HIV/AIDS Research and Interventions
    • Tuberculosis Research and Epidemiology
    • HIV-related health complications and treatments

Papers in

Sherene Min

45 papers receiving 4.7k citations

Sherene Min's Hit Papers

Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study 2014 · 436 citations
4360+4+8Years since publication200400600

Peers

Sherene Min
Comparison fields: 5 of 54
  • Infectious Diseases 3.8k
  • Emergency Medicine 159
  • Virology 95
  • Pharmacology 107
  • Analytical Chemistry 62
Replace Ivy H. Song with:
Ivy H. Song United States
Sara Gibbons United Kingdom
José Moltó Spain
Brian Woodfall United Kingdom
Aurélie Barrail‐Tran France
Lillian S. L. Ting Canada
Angela P. H. Colbers Netherlands
Paul A. Pham United States
Dion F. Coakley United States
William D. Fiske United States
Sherene Min relative to Ivy H. Song United States Ivy H. Song's profile →
Citations per field
00.5×2×3×4×4.5×
Ivy H. Song · 1×
Citations per year

Countries citing papers authored by Sherene Min

Since Specialization
Citations

This map shows the geographic impact of Sherene Min's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherene Min with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherene Min more than expected).

Fields of papers citing papers by Sherene Min

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherene Min. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherene Min. The network helps show where Sherene Min may publish in the future.

Co-authors

The 25 scholars most cited alongside Sherene Min, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sherene Min Line = papers co-authored together Sherene Min links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection
Hit paper breakdown →
2013726
2
Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study
Hit paper breakdown →
2013476
3
Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study
Hit paper breakdown →
2013451
4
Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study
Hit paper breakdown →
2014436
5 2013327
6 2014282
7 2012264
8 2011263
9 2009220
10 2011194
11 2013143
12 2013123
13 2013108
14 200473
15 201573
16 201167
17 201163
18 201057
19 201552
20 200948

About Sherene Min

Sherene Min is a scholar working on Infectious Diseases, Virology, Molecular Medicine, Anesthesiology and Pain Medicine and Cardiology and Cardiovascular Medicine, having authored 50 papers that have together received 4.9k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (38 papers), Cardiac electrophysiology and arrhythmias (2 papers), HIV-related health complications and treatments (1 paper), Pharmacogenetics and Drug Metabolism (1 paper), Anesthesia and Sedative Agents (1 paper), HIV Research and Treatment (1 paper), Antibiotic Resistance in Bacteria (1 paper) and Pharmaceutical studies and practices (1 paper). The work is most often cited by research in Infectious Diseases (3.8k citations), Emergency Medicine (159 citations), Virology (95 citations), Pharmacology (107 citations) and Analytical Chemistry (62 citations). Sherene Min has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Ivy H. Song, Yu Lou, Tamio Fujiwara, Clare A. Brennan, Stephen C. Piscitelli, Julie Borland, Franco Maggiolo, François Raffi, Brian Wynne and Catherine Granier. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, JAIDS Journal of Acquired Immune Deficiency Syndromes, British Journal of Clinical Pharmacology, AIDS and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact